Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
Vanda receives FDA rejection, issues fiery response
The biotech came out swinging after the blow, accusing the FDA of sending a complete response letter that generally disregarded the evidence.
Nick Paul Taylor
Sep 19, 2024 8:02am
FDA scraps adcomm for Applied's rare disease drug
Sep 18, 2024 8:00am
More collaborative FDA can accelerate rare disease R&D: report
Sep 13, 2024 5:00am
Procept BioRobotics gets FDA nod for prostate surgery system
Aug 23, 2024 1:00pm
FDA allows BioNTech-MediLink ADC trial to resume at lower doses
Aug 19, 2024 8:45am
Stoke's Dravet syndrome med released of partial clinical hold
Aug 7, 2024 8:54am